ART Fertility Clinics to Present 18 Accepted Abstracts at ESHRE 2026 in London

The IVI RMA Global network will deliver three selected oral communications and 15 poster presentations across all four days of the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology, 5–8 July at ExCeL London.

ABU DHABI, UAE — 3 July 2026 — ART Fertility Clinics, part of IVI RMA Global, today confirmed its participation in the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE 2026), taking place 5–8 July 2026 at ExCeL London. The group arrives at one of the world’s foremost reproductive medicine congresses with 18 accepted abstracts — comprising 3 selected oral communications and 15 poster presentations — shared across all four congress days.

The programme reflects ART Fertility Clinics’ sustained investment in research that translates directly into patient care, spanning individualised ovarian stimulation, euploid embryo transfer and endometrial preparation, preimplantation genetic testing and embryology innovation. The clinicians and scientists behind the work have together published more than 160 papers in high-impact journals.

Live updates from the oral communications, the 15 posters and the team’s activities on the ground will stream throughout the congress at eshre.artfertilityclinics.com